Clean Diesel Technologies Signs Agreement with TKK

Clean Diesel Technologies, an integrated producer and marketer of emissions control products and systems for the light duty vehicle and heavy duty diesel markets, and Tanaka Kikinzoku Kogyo Kabushiki Kaisha (TKK) have entered an agreement to deliver catalyst engineering and support services for Mixed Phase Catalyst (MPC) emission control technology installation in the Chinese market. TKK is a joint venture partner of Clean Diesel Technologies in the Asia Pacific.

TTK and CDGM Glass are forming a joint venture to manufacture and distribute the catalysts to the automobile industry in China. CDGM Glass is one of China’s leading optoelectronic materials suppliers.

Under the terms of the agreement, the emission control technology of Clean Diesel Technologies will be integrated with the industrial products manufacturing capabilities of TKK and CDGM’s expertise in the Chinese automobile sector. Clean Diesel Technologies will support TTK to establish a catalyst manufacturing venture in China. Clean Diesel will get $1.45 million for the current project.

Clean Diesel Technologies’ CEO, Charles Call stated that the partnership with TKK supports commercialization of the MPC catalyst technology in the rapidly growing Chinese market.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Clean Diesel Technologies Signs Agreement with TKK. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=29313.

  • MLA

    Chai, Cameron. "Clean Diesel Technologies Signs Agreement with TKK". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=29313>.

  • Chicago

    Chai, Cameron. "Clean Diesel Technologies Signs Agreement with TKK". AZoM. https://www.azom.com/news.aspx?newsID=29313. (accessed November 24, 2024).

  • Harvard

    Chai, Cameron. 2019. Clean Diesel Technologies Signs Agreement with TKK. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=29313.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.